Covered recipient · General Payments record
BEVERLY SMITH
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2021–2024
$1,133.44
- Reported across 72 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $294.47 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $97.50 | 6 |
| Lilly USA, LLC | $52.99 | 3 |
| ABBVIE INC. | $50.38 | 3 |
| Novo Nordisk AS | $30.89 | 2 |
| Krystal Biotech Inc | $20.63 | 1 |
| Phathom Pharmaceuticals, Inc. | $15.41 | 1 |
| ITI, Inc. | $14.25 | 1 |
| Dynavax Technologies Corporation | $12.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.14 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106121434 | CMS |
| ABBVIE INC. | $14.89 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106121436 | CMS |
| ABBVIE INC. | $19.35 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106121438 | CMS |
| Dynavax Technologies Corporation | $12.42 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082145153 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14.25 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143323390 | CMS |
| Krystal Biotech Inc | $20.63 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084811170 | CMS |
| Lilly USA, LLC | $18.90 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136013281 | CMS |
| Lilly USA, LLC | $18.82 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136013279 | CMS |
| Lilly USA, LLC | $15.27 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136063612 | CMS |
| Novo Nordisk Inc | $16.68 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097100919 | CMS |
| Novo Nordisk Inc | $14.21 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096970786 | CMS |
| PFIZER INC. | $15.90 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131264843 | CMS |
| PFIZER INC. | $16.43 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131382882 | CMS |
| PFIZER INC. | $15.80 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131333302 | CMS |
| PFIZER INC. | $16.43 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131476742 | CMS |
| PFIZER INC. | $16.45 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131682303 | CMS |
| PFIZER INC. | $16.49 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132040477 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.41 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151127526 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.